Pulmonx Corporation (LUNG) Tops Q3 EPS by 4c

Pulmonx Corporation (NASDAQ: LUNG) reported Q3 EPS of ($0.39), $0.04 better than the analyst estimate of ($0.43). Revenue for the quarter came in at $17.7 million versus the consensus estimate of $16.39 million.

For earnings history and earnings-related data on Pulmonx Corporation (LUNG) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• DA Davidson Reiterates Buy Rating on Boost Run (BRUN)
• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance